V565, A NOVEL ORAL DOMAIN ANTIBODY TO TNF, REDUCES COLONIC MUCOSAL INFLAMMATION AFTER 7 DAYS ORAL DOSING TO PATIENTS WITH ULCERATIVE COLITIS

Suhail Nurbhai  1     Gareth Parkes  2     Mike West  1     Keith Ray  1     Anna Vossenkaemper  3     Patrick Round  1     Tom MacDonald  4     Scott Crowe    
1 VHsquared Ltd,Cambridge,United Kingdom
2 Barts Health NHS Trust,London,United Kingdom
3 Queen Mary University of London,Blizard Institute,London,United Kingdom
4 Queen Mary University of London,Blizard Institute,London

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing